Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIV(mne) infection depends critically on timing of initiation and duration of treatment

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4265-4273

  Tsai, Che Chung ^a,d   Emau, Peter ^a   Follis, Kathryn E ^a   Beck, Thomas W ^a   Benveniste, Raoul E ^b   Bischofberger, Norbert ^c   Lifson, Jeffrey D ^b   Morton, William R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GILEAD SCIENCES   (United States)

^d Pacific Medical Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; INFECTION PREVENTION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0031979775     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4265-4273.1998     Document Type: Article

References (34)

1. Balzarini, J., H. Zhang, P. Herdewijn, D. G. Johns, and E. De Clercq. 1991 Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA 88:1499-1503.
2. Balzarini, J., A. Holy, J. Jindrich, L. Naesens, R. Snoeck, D. Schols, and E. DeClerq. 1993. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(-2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicroh. Agents Chemother. 37: 332-338.
3. Benveniste, R. E., L. O. Arthur, C.-C. Tsai, R. Sowder, T. D. Copeland, L. E. Henderson, and S. Oroszlan. 1986. Isolation of a lentivirus from a macaque with lymphoma: comparison to HTLV-III/LAV and other lentiviruses. J. Virol. 60:483-490.
4. Benveniste, R. E., W. R. Morton, E. A. Clark, C.-C. Tsai, H. D. Ochs, J. M. Ward, L. Kuller, W. B. Knott, R. W. Hill, M. J. Gale, and M. E. Thouless. 1988. Inoculation of baboons and macaques with simian immunodeficiency virus/mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J. Virol. 62:2091-2101.
5. Bertolli, J., M. E. St. Louis, R. J. Simonds, P. Nieburg, M. Kamenga, C. Brown, M. Tarande, T. Quinn, and C. Y. Ou. 1996. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J. Infect. Dis. 174:722-726.
6. Cavert, W., D. W. Notermans, K. Staskus, S. W. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z. Q. Zhang, R. Mills, H. McDade, J. Gouldsmit, S. A. Danner, and A. T. Haase. 1997. Kinetics of response in lymphoid to antiretroviral therapy of HIV-1 infection. Science 276:960-964.
7. Chouquet, C., M. Burgard, S. Richardson, C. Rouzioux, and D. Costagliola. 1997. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 11:1183-1199.
8. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
9. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
10. Fridland, A. Personal communication.
11. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, W. R. Elkins, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
12. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
13. Kalish, L. A., J. Pitt, J. Lew, S. Landesman, C. Diaz, R. Hershow, F. B. Hollinger, M. Pagano, V. Smeriglio, and J. Moye for the Women and Infants Transmission Study (WITS). 1997. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. J. Infect. Dis. 175:712-715.
14. Lifson, J. D., M. Nowak, S. Goldstein, J. L. Rossio, A. Kinter, G. Vasquez, T. A. Wiltrout, C. Bromn, D. Schneider, L. Wahl, A. Lloyd, W. R. Elkins, A. S. Fauci, and V. M. Hirsch. 1997. The extent of early viral replication is a critical determinant of the natural history of AIDS virus infection. J. Virol. 75:9508-9514.
15. Lifson, J. D., M. Nowak, A. Lloyd, and V. M. Hirsch. Clues to primate lentiviral pathogenesis from the study of SIV dynamics. In M. Girrard and B. Dodet (ed.), Retroviruses of human AIDS and related animal diseases, in press. Pasteur Vaccins, Paris, France.
16. Martin, L. N., M. Murphey-Corb, K. F. Soike, B. Davison-Fairburn, and G. B. Baskin. 1993. Effects of initiation of 3′-azido-3′-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J. Infect. Dis. 168:825-835.
17. Nowak, M. A., A. L. Lloyd, G. M. Vasquez, T. A. Wiltrout, L. M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A. S. Fauci, V. M. Hirsch, and J. D. Lifson. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525.
18. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life span, and viral generation time. Science 271:1582-1586.
19. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. Ho. 1997. Decay characteristics of HIV-infected compartments during combination therapy. Nature 387:188-191.
20. Rowland-Jones, S. L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, and T. Corrah. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
21. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Opin. Immunol. 7: 448-455.
22. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21-24.
23. Suryanarayana, K., T. A. Wiltrout, G. M. Vasquez, V. M. Hirsch, and J. D. Lifson. 1998. Plasma SIV RNA viral load by real time quantification of product generation in RT PCR. AIDS Res. Hum. Retroviruses 14:183-189.
24. Tsai, C.-C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270:1197-1199.
25. Tsai, C.-C., K. E. Follis, R. F. Grant, R. E. Nolte, C. R. Bartz, R. E. Benveniste, and P. R. Sager. 1993. Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus. J. Acquired Immune Defic. Syndr. 6:1086-1092.
26. Tsai, C.-C., K. E. Follis, R. F. Grant, R. E. Nolte, H. Wu, and R. E. Benveniste. 1993. Infectivity and pathogenesis of titered dosages of simian immunodeficiency virus (SIV) experimentally inoculated into longtailed macaques (Macaca fascicularis). Lab. Anim. Sci. 43:411-416.
27. Tsai, C.-C., K. E. Follis, A. Sabo, R. F. Grant, C. Bartz, R. E. Nolte, R. E. Benveniste, and N. Bischofberger. 1994. Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques. J. Infect. Dis. 169:260-266.
28. Tsai, C.-C., K. E. Follis, M. Yarnall, L. E. Deaver, R. E. Benveniste, and P. R. Sager. 1990. In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV). Antiviral Res. 14:87-98.
29. Tsai, C.-C., K. E. Follis, T. W. Beck, A. Sabo, N. Bischofberger, and P. J. Dailey. 1997. Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques. AIDS Res. Hum. Retroviruses 13:707-712.
30. Van Rompay, K. K. A., M. L. Marthas, R. A. Ramos, C. P. Mandel, E. K. McGowan, S. M. Joye, and N. C. Pederson. 1992. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy; oral 3′-azido-3′-deoxythymidine prevents SIV infection. Antimicrob. Agents Chemother. 36:2381-2386.
31. Van Rompay, K. K. A., J. M. Cherrington, M. L. Marthas, C. J. Berardi, A. S. Mulato, A. Spinner, R. P. Tarara, D. R. Canfield, S. Telm, N. Bischofberger, and N. C. Pederson. 1996. 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob. Agents Chemother. 40:2586-2591.
32. Watson, A., J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S.-L. Hu, and N. L. Haigwood. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load in early infection predicts survival. J. Virol. 71:284-290.
33. Wei, H., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. R. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
34. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.